Mga Batayang Estadistika
| LEI | 54930020031IDJT2IM79 |
| CIK | 19584 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Chemed Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| July 31, 2025 |
Nicholas M. Westfall Transition and Separation Agreement EXHIBIT 10.1 TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASE This Transition and Separation Agreement and General Release (“Agreement”) is entered into by on the one hand, Nicholas M. Westfall, an individual, (“Executive”), and, on the other hand, Chemed Corporation, along with each and all of its subsidiaries, divisions, affiliates, joint ventures, officers, directors, employees and other |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2025 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 29, 2025 |
Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure CINCINNATI, July 29, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain |
|
| June 27, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant |
|
| June 27, 2025 |
CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714 Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 CINCINNATI, June 27, 2025-Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesda |
|
| June 27, 2025 |
EXHIBIT I CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (File No. |
|
| May 22, 2025 |
As filed with the Securities and Exchange Commission on May 20, 2025 Registration No. |
|
| May 20, 2025 |
EXHIBIT 4.7 Name Address City, State ZIP Code Dear , In accordance with the Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchase price shall be $ per share. Payment thereof shall be made in ca |
|
| May 20, 2025 |
EXHIBIT 24 EXHIBIT 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J. |
|
| May 20, 2025 |
Form of Performance Based Stock Award EXHIBIT 4.8 February 14, 2025 Name Address Dear : I am pleased to inform you that the Compensation/Incentive Committee (the “Committee”) of Chemed Corporation (the "Company"), has granted you a target number of share units, which are the equivalent of one share of the Company's Capital Stock ("Capital Stock"), par value $1.00 per share (“Performance Share Units”), u |
|
| May 20, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 CHEMED CORP Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $1 per share Other 1,100,000 $ 555. |
|
| May 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Addre |
|
| May 20, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 20, 2025 |
EXHIBIT 4.6 Chemed Corporation 2025 Stock Incentive Plan 1. Purpose. The purpose of the Plan is to support the Company’s ongoing efforts to develop and retain excellent Key Employees and to provide them with incentives that are directly linked to the profitability of the Company’s businesses and to increases in stockholder value. 2. Definitions. For purposes of the Plan, the following terms ar |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2025 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 23, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 23, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 23, 2025 |
Chemed Reports First-Quarter 2025 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports First-Quarter 2025 Results CINCINNATI, April 23, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi |
|
| April 7, 2025 |
Important Notice Regarding the Availability of Proxy Materials for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm |
|
| April 1, 2025 |
M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact n |
|
| February 28, 2025 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2024: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 28, 2025 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 28, 2025 |
EXHIBIT 97 Incentive Compensation Recovery Policy A. PURPOSE This Incentive Compensation Recovery Policy (this “Recovery Policy”) is adopted by Chemed Corporation, a Delaware corporation (the “Company”), as of the 3rd day of November, 2023 (the “Effective Date”) as required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 under the Exchange A |
|
| February 28, 2025 |
Insider Trading Policy of Chemed Corporation EXHIBIT 19 INSIDER TRADING POLICY A. INTRODUCTION AND STATEMENT OF PRINCIPLES 1. Chemed Corporation and its subsidiaries or affiliates (collectively, the “Company”) are subject to and shall promote compliance with U.S. federal and state securities laws, including insider trading laws, rules and regulations promulgated by the U.S. Securities and Exchange Commission (the “SEC”), and any appl |
|
| February 28, 2025 |
M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam |
|
| February 26, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 26, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 26, 2025 |
Chemed Reports Fourth-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Fourth-Quarter 2024 Results CINCINNATI, February 26, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported finan |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 29, 2024 |
Chemed Reports Third-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Third-Quarter 2024 Results CINCINNATI, October 29, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi |
|
| October 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 24, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 24, 2024 |
Chemed Reports Second-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Second-Quarter 2024 Results CINCINNATI, July 24, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 ¨ Transition Report Pursuant |
|
| June 26, 2024 |
EXHIBIT I CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (File No. |
|
| June 26, 2024 |
EXHIBIT II CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (No. |
|
| May 21, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 24, 2024 |
Chemed Reports First-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports First-Quarter 2024 Results CINCINNATI, April 24, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial |
|
| April 17, 2024 |
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama CONTACT: Michael D. Witzeman (513) 762-6714 VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama CINCINNATI, April 17, 2024 – VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility f |
|
| April 17, 2024 |
Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 17, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 8, 2024 |
Important Notice Regarding the Availability of Proxy Materials for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm |
|
| March 13, 2024 |
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama CONTACT: Michael D. Witzeman (513) 762-6714 VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama CINCINNATI, March 13, 2024 – VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Co |
|
| March 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 29, 2024 |
EXHIBIT 97 Incentive Compensation Recovery Policy A. PURPOSE This Incentive Compensation Recovery Policy (this “Recovery Policy”) is adopted by Chemed Corporation, a Delaware corporation (the “Company”), as of the 3rd day of November, 2023 (the “Effective Date”) as required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 under the Exchange A |
|
| February 29, 2024 |
M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam |
|
| February 29, 2024 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 29, 2024 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2023: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 27, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 27, 2024 |
Chemed Reports Fourth-Quarter 2023 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Fourth-Quarter 2023 Results CINCINNATI, February 27, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported fin |
|
| February 13, 2024 |
CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 1, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 1, 2024 |
David P. Williams Performance Share Units Grant Letter dated January 29, 2024 January 29, 2024 Dear Mr. Williams: In connection with your transition from Chief Financial Officer and Executive Vice President of Chemed Corporation (the “Company”) to an employee in an advisory role to the Chief Executive Officer, I am please to inform you that you have been granted a target number of 6,424 share units, which are the equivalent of one share of the Comp |
|
| December 18, 2023 |
Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO CINCINNATI, December 18, 2023-Chemed Corporation (NYSE: CHE) – Today Chemed Corporation’s Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzema |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 18, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 3, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| November 3, 2023 |
Chemed Corporation Announces the Retirement of David P. Williams CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Corporation Announces the Retirement of David P. Williams CINCINNATI, November 3, 2023-Chemed Corporation (NYSE: CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed’s Chief Financial Officer as of December 31, 2023, but Mr. Williams will co |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 27, 2023 |
October 27, 2023 Ms. Tracey Houser and Ms. Jeanne Baker United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2022 Filed February 27, 2023 Response Letter Dated October 16, 2023 File No. 001-08351 Dear Ms. Houser and Ms. B |
|
| October 25, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 30, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 25, 2023 |
Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance CINCINNATI, October 25, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning servic |
|
| October 16, 2023 |
October 16, 2023 Ms. Tracey Houser and Ms. Jeanne Baker United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2022 Filed February 27, 2023 File No. 001-08351 Dear Ms. Houser and Ms. Baker: On behalf of Chemed Corporation ( |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 26, 2023 |
Chemed Reports Second-Quarter 2023 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2023 Results CINCINNATI, July 26, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial res |
|
| June 28, 2023 |
EXHIBIT 1 We consent to the incorporation by reference in the Registration Statement (Nos. |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 ¨ Transition Report Pursuant |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 15, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 31, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 26, 2023 |
Chemed Reports First-Quarter 2023 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports First-Quarter 2023 Results CINCINNATI, April 26, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial r |
|
| April 6, 2023 |
Important Notice Regarding the Availability of Proxy Materials for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm |
|
| February 27, 2023 |
Form of Stock Option Grant - 2022 Exhibit 10.29 Chemed Corporation Form of Stock Option Grant – 2022 Date Name Address City, State ZIP Code Dear , In accordance with the 2022 Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchas |
|
| February 27, 2023 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 27, 2023 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2022: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 27, 2023 |
M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam |
|
| February 23, 2023 |
Chemed Reports Fourth-Quarter 2022 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2022 Results CINCINNATI, February 23, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported finan |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 9, 2023 |
CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| December 9, 2022 |
Amended and Restated By-Laws of Chemed Corporation, effective as of December 9, 2022 BY-LAWS of CHEMED CORPORATION (As amended through December 9, 2022) AMENDED AND RESTATED BY-LAWS of CHEMED CORPORATION (a Delaware Corporation) ARTICLE I Meeting of Stockholders Section 1. |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 31, 2022 |
Chemed Reports Third-Quarter 2022 Results – Increases 2022 Earnings Guidance ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Third-Quarter 2022 Results ? Increases 2022 Earnings Guidance ? CINCINNATI, October 31, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning |
|
| October 31, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 31, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 27, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Nu |
|
| July 27, 2022 |
Chemed Reports Second-Quarter 2022 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Second-Quarter 2022 Results ? CINCINNATI, July 27, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial |
|
| June 29, 2022 |
? ? ? CONTACT: David P. Williams FOR IMMEDIATE RELEASE (513) 762-6901 ? ? Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility ? ? CINCINNATI, June 29, 2022-Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $550 million of amended and restated senior secured credit facilities (?Credit Facilities?). JPMorgan Chase Bank, |
|
| June 29, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 29, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdicti |
|
| June 29, 2022 |
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 28, 2022 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N. |
|
| June 23, 2022 |
11-K 1 a52760217.htm CHEMED CORPORATION 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ☒ Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 |
|
| May 17, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Num |
|
| May 16, 2022 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J. |
|
| May 16, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Address of principal ex |
|
| May 16, 2022 |
Exhibit 4.6 Chemed Corporation 2022 Stock Incentive Plan 1. Purpose. The purpose of the Plan is to support the Company?s ongoing efforts to develop and retain excellent Key Employees and to provide them with incentives that are directly linked to the profitability of the Company?s businesses and to increases in stockholder value. 2. Definitions. For purposes of the Plan, the following terms are de |
|
| May 16, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Chemed Corporation (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Type Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $1. |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 26, 2022 |
Chemed Reports First-Quarter 2022 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports First-Quarter 2022 Results ? CINCINNATI, April 26, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial |
|
| April 26, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N |
|
| April 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (a |
|
| February 28, 2022 |
Senior Executive Severance Policy as amended August 3, 2018 EXHIBIT 10.20 CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 As of December 1, 2006, Chemed Corporation established the Chemed Corporation Senior Executive Severance Policy (?the Policy?). As of August 3, 2018 (the "Amendment Date"), the Company amended the Policy to provide that the tax gross-up provisions in Section 3.1 shall apply only to those individuals who we |
|
| February 28, 2022 |
EXHIBIT 24 ? POWER OF ATTORNEY ? The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 28, 2022 |
Subsidiaries of Chemed Corporation EXHIBIT 21 ? SUBSIDIARIES OF CHEMED CORPORATION ? The following is a list of subsidiaries of the Company as of December 31, 2021: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 28, 2022 |
Change in Control Severance Plan as amended August 3, 2018 EXHIBIT 10.19 CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 ESTABLISHMENT and amendment OF PLAN As of the Effective Date, the Company (as such term is hereinafter defined) established the Chemed Corporation Change in Control Severance Plan, as set forth in this document. As of the Amendment Date, the Company amended the Plan to provide that the tax gross-up provisio |
|
| February 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 24, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission Fil |
|
| February 24, 2022 |
Chemed Reports Fourth-Quarter 2021 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Fourth-Quarter 2021 Results ? CINCINNATI, February 24, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported finan |
|
| February 9, 2022 |
CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File |
|
| October 28, 2021 |
Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased EX-99 2 che-20211028xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased CINCINNATI, October 28, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercia |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 27, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Nu |
|
| July 27, 2021 |
Chemed Reports Second-Quarter 2021 Results – Full-Year 2021 Guidance Increased EX-99 2 che-20210727xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2021 Results – Full-Year 2021 Guidance Increased CINCINNATI, July 27, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and resid |
|
| June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K/A For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ? Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13 |
|
| June 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ? Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13 o |
|
| May 19, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Num |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 27, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N |
|
| April 27, 2021 |
Chemed Corporation (CHE) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 Chemed Corporation Shareholder since 2015 Please support proposal topic that won our 48% support in 2020 Political Spending Disclosure A 48% vote means that that the shares that had access to objective voting advice were more than 50% in favor. |
|
| April 27, 2021 |
Chemed Reports First-Quarter 2021 Results CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports First-Quarter 2021 Results ? CINCINNATI, April 27, 2021?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial r |
|
| April 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (a |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 26, 2021 |
EXHIBIT 24 ? POWER OF ATTORNEY ? The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 26, 2021 |
Subsidiaries of Chemed Corporation EXHIBIT 21 ? SUBSIDIARIES OF CHEMED CORPORATION ? The following is a list of subsidiaries of the Company as of December 31, 2020: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 23, 2021 |
Chemed Reports Fourth-Quarter 2020 Results EX-99 2 che-20210223xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2020 Results CINCINNATI, February 23, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleani |
|
| February 23, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission Fil |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| November 30, 2020 |
November 30, 2020 Mr. Tim Buchmiller and Ms. Celeste Murphy United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2019 Filed February 26, 2020 File No. 001-08351 Dear Mr. Buchmiller and Ms. Murphy: On behalf of Chemed Corporation (the “Company”) |
|
| November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| October 29, 2020 |
Chemed Reports Third-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2020 Results CINCINNATI, October 29, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi |
|
| September 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 31, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| July 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 30, 2020 |
Chemed Reports Second-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2020 Results CINCINNATI, July 29, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial r |
|
| July 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ☒ Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 ☐ Transition Report Pursuant to Section 13 o |
|
| May 19, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 28, 2020 |
Chemed Reports First-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports First-Quarter 2020 Results CINCINNATI, April 28, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial |
|
| April 28, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 28, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 22, 2020 |
CHE / Chemed Corp. DEFA14A - - CHEMED CORP. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a |
|
| April 22, 2020 |
Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting CONTACT: David P. Williams (513) 762-6901 Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting CINCINNATI, April 22, 2020-Chemed Corporation (NYSE:CHE) announced today that the Company will hold its 2020 Annual Meeting of Stockholders in a virtual-only format due to public health concerns relating to the coronavirus (COVID-19) and to protect the health and well-being of its sto |
|
| April 22, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 22, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 15, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 9, 2020 |
CHE / Chemed Corp. DEF 14A - - CHEMED CORPORATION DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a |
|
| March 13, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 13, 2020 |
Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase CINCINNATI, March 13, 2020-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $250 million for stock repurchase under Chemed’s existing share repurchase program. These share repurch |
|
| February 26, 2020 |
Form of Stock Option Grant - 2018 Exhibit 10.29 Chemed Corporation Form of Stock Option Grant - 2019 Name Address City, State ZIP Code Dear , In accordance with the 2018* Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase 2018 shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchase |
|
| February 26, 2020 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 26, 2020 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2019: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 26, 2020 |
EXHIBIT 4.1 Description of the Company’s Capital Stock The following description of Chemed Corporation’s capital stock is based on and qualified by the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and our By-laws, as amended (the “By-laws”). This description does not purport to be complete, or to give full effect to the provisions of statutory or com |
|
| February 18, 2020 |
Chemed Reports Fourth-Quarter 2019 Results Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2019 Results CINCINNATI, February 18, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, |
|
| February 18, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 12, 2020 |
CHE / Chemed Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| November 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 30, 2019 |
Chemed Reports Third-Quarter 2019 Results Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2019 Results CINCINNATI, October 29, 2019—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, repor |
|
| October 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| September 17, 2019 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 17, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission Fi |
|
| September 17, 2019 |
Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Roto-Rooter Completes the Previously Announced Purchase of Assets of Its Largest Independent Franchise Operator CINCINNATI, September 16, 2019 – Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of HSW RR, Inc.’s (“HSW”) franchise |
|
| August 5, 2019 |
Chemed Corporation Releases Updated Guidance CONTACT: David P. Williams (513) 762-6901 Chemed Corporation Releases Updated Guidance CINCINNATI, August 5, 2019-The VITAS and Chemed (NYSE:CHE) updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS on July 31, 2019, and effective October 1, 2019. This updated guidance also includes certain increased costs related to revenue pass-through under cer |
|
| August 5, 2019 |
Roto-Rooter To Buy Assets of Its Largest Independent Franchise Operator CONTACT: David P. Williams (513) 762-6901 Roto-Rooter To Buy Assets of Its Largest Independent Franchise Operator CINCINNATI, August 5, 2019 – Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has entered into an agreement to acquire all of HSW RR, Inc.’s (“HSW”) franchise operations and Western Drain Supply for an aggregate purch |
|
| August 5, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| July 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 25, 2019 |
Chemed Reports Second-Quarter 2019 Results Exhibit 99 Chemed Reports Second-Quarter 2019 Results CINCINNATI-(BUSINESS WIRE)-July 25, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2019, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 7. |
|
| July 25, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdicti |
|
| May 22, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1‑8351 31‑0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdictio |
|
| May 2, 2019 |
Quarterly Report - CHEMED CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 29, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51973296.htm CHEMED CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 29, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdic |
|
| April 29, 2019 |
Chemed Reports First-Quarter 2019 Results Exhibit 99 Chemed Reports First-Quarter 2019 Results CINCINNATI-(BUSINESS WIRE)-April 29, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2019, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5. |
|
| April 9, 2019 |
CHE / Chemed Corp. CHEMED CORP. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a |
|
| February 27, 2019 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2018: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 27, 2019 |
2018 Annual Report to Stockholders EXHIBIT 13 Financial Review Contents Report of Independent Registered Public Accounting Firm 61 Consolidated Statements of Income 63 Consolidated Balance Sheets 64 Consolidated Statements of Cash Flows 65 Consolidated Statements of Changes in Stockholders’ Equity 66 Notes to Consolidated Financial Statements 67 Unaudited Summary of Quarterly Results 93 Selected Financial Data 95 Unaudited Consolid |
|
| February 27, 2019 |
Plan as amended August 3, 2018. EXHIBIT 10.19 CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 ESTABLISHMENT AND AMENDMENT OF PLAN As of the Effective Date, the Company (as such term is hereinafter defined) established the Chemed Corporation Change in Control Severance Plan, as set forth in this document. As of the Amendment Date, the Company amended the Plan to provide that the tax gross-up provisio |
|
| February 27, 2019 |
CHE / Chemed Corp. CHEMED CORP. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 27, 2019 |
Policy as amended August 3, 2018. EXHIBIT 10.20 CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 As of December 1, 2006, Chemed Corporation established the Chemed Corporation Senior Executive Severance Policy (“the Policy”). As of August 3, 2018 (the "Amendment Date"), the Company amended the Policy to provide that the tax gross-up provisions in Section 3.1 shall apply only to those individuals who we |
|
| February 27, 2019 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 25, 2019 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 25, 2019 |
Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase Exhibit 99 Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase CINCINNATI-(BUSINESS WIRE)-February 25, 2019-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $150 million for stock repurchase under Chemed’s existing share repurchase program. |
|
| February 20, 2019 |
Chemed Reports Fourth-Quarter 2018 Results Exhibit 99 Chemed Reports Fourth-Quarter 2018 Results CINCINNATI-(BUSINESS WIRE)-February 20, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| February 20, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 20, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 13, 2019 |
CHE / Chemed Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* CHEMED CORPORATION (Name of Issuer) Common (Title of Class of Securities) 16359R103 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| February 11, 2019 |
CHE / Chemed Corp. / VANGUARD GROUP INC Passive Investment chemedcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10 )* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designate |
|
| December 6, 2018 |
December 6, 2018 Mr. Craig Arakawa, Accounting Branch Chief United States Securities and Exchange Commission Division of Corporation Finance Office of Beverages, Apparel and Mining 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2017 Filed February 26, 2018 File No. 001-08351 Dear Mr. Arakawa: On behalf of Chemed Corporation (“Chemed” or the |
|
| November 2, 2018 |
CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 29, 2018 |
Chemed Reports Third-Quarter 2018 Results - Earnings Guidance Increased Exhibit 99 Chemed Reports Third-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI-(BUSINESS WIRE)-October 29, 2018-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| October 29, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| October 1, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 1, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 1, 2018 |
Roto-Rooter Buys Five Northern California Franchises – Acquisition is the Company’s Largest to Date Exhibit 99 Roto-Rooter Buys Five Northern California Franchises – Acquisition is the Company’s Largest to Date CINCINNATI-(BUSINESS WIRE)-October 1, 2018-Chemed Corporation ("Chemed") (NYSE:CHE) today announced its Roto-Rooter Services Company subsidiary has acquired five formerly independent Roto-Rooter franchises covering several areas of Northern California. |
|
| July 30, 2018 |
CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 25, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 25, 2018 |
Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased Exhibit 99 Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI-(BUSINESS WIRE)-July 25, 2018-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| June 22, 2018 |
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement EX-99.1 3 a51826107ex991.htm EXHIBIT 99.1 Exhibit 99.1 Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI-(BUSINESS WIRE)-June 21, 2018-Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility (“Credit Agreement”). JPMorgan Chase Bank, N.A., acted as the Administr |
|
| June 22, 2018 |
As of June 20, 2018 exhibits and schedules thereto. EX-10.1 2 a51826107ex101.htm EXHIBIT 10.1 Exhibit 10.1 J.P. Morgan FOURTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 20, 2018 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N.A., as Syndication Agent, U.S. BANK NATIONAL ASSOCIATION, as Documentation Agent and JPMORGAN CHASE BANK, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A. and MERRILL LYNCH, PIERCE, FEN |
|
| June 22, 2018 |
Entry into a Material Definitive Agreement 8-K 1 a51826107.htm CHEMED CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 20, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1‑8351 31‑0791746 (State or other (Commission Fil |
|
| May 23, 2018 |
EXHIBIT 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J. |
|
| May 23, 2018 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Address of principal ex |
|
| May 23, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 21, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| April 27, 2018 |
CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 19, 2018 |
Chemed Reports First-Quarter 2018 Results Exhibit 99 Chemed Reports First-Quarter 2018 Results CINCINNATI-(BUSINESS WIRE)-April 19, 2018-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 8. |
|
| April 19, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 19, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 11, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| March 6, 2018 |
Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase Exhibit 99 Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase CINCINNATI-(BUSINESS WIRE)-March 6, 2018-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $150 million for stock repurchase under Chemed’s existing share repurchase program. |
|
| March 6, 2018 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 6, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| February 26, 2018 |
Computation of Ratio of Earnings EXHIBIT 12 CHEMED CORPORATION COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (in thousands, except ratios) 2013 2014 2015 2016 2017 Pretax income from continuing operations $ 123,829 $ 162,754 $ 180,126 $ 177,054 $ 116,917 Additions: Fixed charges 28,032 21,388 16,985 17,060 18,009 Amortization of capitalized interest 435 435 435 435 109 Adjusted income $ 152,296 $ 184,577 $ 197,546 $ 194,549 $ 135,035 Fixed Charges: Interest expense $ 15,035 $ 8,186 $ 3,645 $ 3,715 $ 4,272 Interest component of rental expense 12,997 13,202 13,340 13,345 13,737 Fixed charges $ 28,032 $ 21,388 $ 16,985 $ 17,060 $ 18,009 Ratio of earnings to fixed charges (a) 5. |
|
| February 26, 2018 |
Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2017: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 26, 2018 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 26, 2018 |
CHE / Chemed Corp. CHEMED CORPORATION 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☑ For the fiscal year ended December 31, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 26, 2018 |
2017 Annual Report to Stockholders EXHIBIT 13 Financial Review Contents Report of Independent Registered Public Accounting Firm 45 Consolidated Statements of Income 47 Consolidated Balance Sheets 48 Consolidated Statements of Cash Flows 49 Consolidated Statements of Changes in Stockholders’ Equity 50 Notes to Consolidated Financial Statements 51 Unaudited Summary of Quarterly Results 76 Selected Financial Data 78 Unaudited Consolid |
|
| February 23, 2018 |
CHE / Chemed Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) Chemed Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 16359R103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive |
|
| February 15, 2018 |
CHE / Chemed Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* CHEMED CORPORATION (Name of Issuer) Common (Title of Class of Securities) 16359R103 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| February 14, 2018 |
Chemed Reports Fourth-Quarter 2017 Results Exhibit 99 Chemed Reports Fourth-Quarter 2017 Results CINCINNATI-(BUSINESS WIRE)-February 14, 2018-Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation?s largest provider of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2017, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| February 14, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 9, 2018 |
CHE / Chemed Corp. / VANGUARD GROUP INC Passive Investment chemedcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9 )* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designate |
|
| November 2, 2017 |
Chemed Settles DOJ Litigation No Admission or Determination of Wrongdoing Exhibit 99.1 Chemed Settles DOJ Litigation No Admission or Determination of Wrongdoing CINCINNATI-(BUSINESS WIRE)-October 31, 2017-Chemed Corporation (Chemed) (NYSE: CHE), the parent company of VITAS Healthcare Corporation (“VITAS”), announced today that they have reached final agreement to end the civil litigation and False Claims Act brought by the U.S. Department of Justice (“DOJ”) in May 2013. |
|
| November 2, 2017 |
Exhibit 10.02 CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND VITAS HOSPICE SERVICES, L.L.C., VITAS HEALTHCARE CORPORATION, VITAS HEALTHCARE CORPORATION OF CALIFORNIA, VITAS HEALTHCARE CORPORATION OF ILLINOIS, VITAS HEALTHCARE CORPORATION OF FLORIDA, VITAS HEALTHCARE CORPORATION OF OHIO, VITAS HEALTHCARE CORPORATION OF ATLANT |
|
| November 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 30, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1?8351 31?0791746 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 2, 2017 |
Exhibit 10.01 SETTLEMENT AGREEMENT This Settlement Agreement ("Agreement") is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General ("OIG-HHS") of the Department of Health and Human Services (HHS) (collectively, the "United States"), VITAS Hospice Services, L.L.C., VITAS Healthcare Corporation, VITAS |
|
| October 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp |
|
| October 26, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): October 26, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| October 26, 2017 |
Chemed Reports Third-Quarter 2017 Results -Increases Full-Year Guidance- Exhibit 99 Chemed Reports Third-Quarter 2017 Results -Increases Full-Year Guidance- CINCINNATI-(BUSINESS WIRE)-October 26, 2017-Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation?s largest provider of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2017, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| July 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi |
|
| July 25, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): July 25, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 25, 2017 |
Chemed Reports Second-Quarter 2017 Results -Earnings Guidance Increased- Exhibit 99 Chemed Reports Second-Quarter 2017 Results -Earnings Guidance Increased- CINCINNATI-(BUSINESS WIRE)-July 25, 2017-Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation?s largest provider of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2017, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6. |
|
| May 17, 2017 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 15, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1?8351 31?0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdictio |
|
| April 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif |
|
| April 26, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): April 26, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 26, 2017 |
Chemed Reports First-Quarter 2017 Results Exhibit 99 Chemed Reports First-Quarter 2017 Results CINCINNATI-(BUSINESS WIRE)-April 26, 2017-Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation?s largest provider of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2017, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 4. |
|
| April 10, 2017 |
Chemed CHEMED CORPORATION DEF 14A NOTICE OF ANNUAL MEETING OF STOCKHOLDERS MAY 15, 2017 The Annual Meeting of Stockholders of Chemed Corporation will be held at The Queen City Club, 331 East Fourth Street, Cincinnati, Ohio, on May 15, 2017, at 11:00 a. |
|
| April 3, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 31, 2017 Date of Report (date of earliest event reported): CHEMED CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 1-8351 31-0791746 (State or Other Jurisdiction of Incorporation or Organization) (Com |
|
| March 31, 2017 |
Chemed CHEMED CORPORATION PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (a |
|
| March 13, 2017 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): March 10, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 13, 2017 |
Chemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase Exhibit 99 Chemed Corporation?s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase CINCINNATI-(BUSINESS WIRE)-March 13, 2017-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed?s existing share repurchase program. |
|
| March 7, 2017 |
CHE / Chemed Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Chemed Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 16359R103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive |
|
| February 27, 2017 |
EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J. |
|
| February 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☑ For the fiscal year ended December 31, 2016 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name |
|
| February 27, 2017 |
EXHIBIT 12 CHEMED CORPORATION COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (in thousands, except ratios) 2012 2013 2014 2015 2016 Pretax income from continuing operations $ 145,819 $ 123,829 $ 162,754 $ 180,126 $ 177,054 Additions: Fixed charges 28,021 28,032 21,388 16,985 17,060 Amortization of capitalized interest 435 435 435 435 435 Adjusted income $ 174,275 $ 152,296 $ 184,577 $ 197,546 $ 194,549 Fixed Charges: Interest expense $ 14,723 $ 15,035 $ 8,186 $ 3,645 $ 3,715 Interest component of rental expense 13,298 12,997 13,202 13,340 13,345 Fixed charges $ 28,021 $ 28,032 $ 21,388 $ 16,985 $ 17,060 Ratio of earnings to fixed charges (a) 6. |
|
| February 27, 2017 |
EXHIBIT 13 Financial Review Contents Report of Independent Registered Public Accounting Firm 43 Consolidated Statement of Income 44 Consolidated Balance Sheet 45 Consolidated Statement of Cash Flows 46 Consolidated Statement of Changes in Stockholders’ Equity 47 Notes to Consolidated Financial Statements 48 Unaudited Summary of Quarterly Results 71 Selected Financial Data 73 Unaudited Consolidatin |
|
| February 27, 2017 |
SUBSIDIARIES OF CHEMED CORPORATION EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2016: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary. |
|
| February 17, 2017 |
By-Laws of Chemed Corporation as amended December 9, 2022 Exhibit 3.1 Section 1.03. Special Meetings. (a) Special meetings of stockholders, for any purpose or purposes, may be called at any time by the Chairman of the Board, the Chief Executive Officer, the President or the Secretary, and shall be called by the Chairman of the Board, the Chief Executive Officer, the President or the Secretary upon the written request of a majority of the Board of Directo |
|
| February 17, 2017 |
Chemed CHEMED CORPORATION 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 17, 2017 CHEMED CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 15, 2017 |
Chemed Reports Fourth-Quarter 2016 Results Exhibit 99 Chemed Reports Fourth-Quarter 2016 Results CINCINNATI-(BUSINESS WIRE)-February 15, 2017-Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation?s largest provider of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2016, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1. |
|
| February 15, 2017 |
Chemed CHEMED CORPORATION 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): February 15, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2017 |
CHE / Chemed Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHEMED CORPORATION (Name of Issuer) Common (Title of Class of Securities) 16359R103 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| February 10, 2017 |
CHE / Chemed Corp. / VANGUARD GROUP INC Passive Investment chemedcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8 )* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate |
